HID Global, a worldwide provider in trusted identity solutions, shared its expertise in electronic prescriptions at this week’s opioid policy hearing that was conducted by the Food & Drug Administration (FDA). HID is urging policymakers to address the opioid abuse crisis in the United States by linking electronic prescriptions for controlled substances (EPCS) with prescription drug monitoring program databases. Electronic prescriptions of painkillers (opioids), such as oxycodone, morphine and methadone, will help modernise public health practices.
The country’s opioid abuse crisis creates a demand for a new level of trust to be injected into the entire process of doctors’ prescribing painkillers. E-prescriptions with digital certificates would accomplish this goal.
